Teknova Announces Preliminary Third Quarter Financial Results
Stocks in this Quantisnow insightHealth Care
Historical context for TKNO
Across the 12 sessions after earlier TKNO headlines, the stock closed higher 7 times and lower 4 times, with a median move of 3.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | TKNO | SPY |
|---|---|---|---|
| Oct 5, 2026 | Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System | +0.1% | +0.7% |
| Sep 17, 2026 | Jefferies initiated coverage on Alpha Teknova with a new price targetand 1 other headline that session | +4.8% | +1.1% |
| Aug 11, 2026 | Alpha Teknova upgraded by BTIG Research with a new price target | +4.8% | -0.3% |
| Aug 6, 2026 | Teknova Reports Second Quarter 2026 Financial Results | +16.4% | -0.2% |
| Aug 5, 2026 | Teknova Launches Build-Tek™, a Proprietary AI Reagent Assistant That Allows Customers to Configure Complex Custom Product Requests in Minutesand 1 other headline that session | +1.6% | -0.2% |
| Jul 23, 2026 | Teknova to Report Second Quarter 2026 Financial Results on August 5, 2026 | -0.8% | -1.2% |
Quantisnow market dataNASDAQ
TKNO
Alpha Teknova Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Listed since
- 2021
Get push alerts for TKNO
Full TKNO profile on Quantisnow Follow TKNO and get a push notification the moment its next story breaks.